Literature DB >> 7702557

Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.

A Takai1, K Sasaki, H Nagai, G Mieskes, M Isobe, K Isono, T Yasumoto.   

Abstract

Several groups have reported that okadaic acid (OA) and some other tight-binding protein phosphatase inhibitors including microcystin-LR (MCLR), calyculin-A and tautomycin prevent each other from binding to protein phosphatase 2A (PP2A). In this paper, we have introduced an improved procedure for examining to what extent the affinity of an enzyme for a labelled tight-binding ligand is reduced by binding of an unlabelled tight-binding, ligand to the enzyme. Using this procedure, we have analysed the dose-dependent reduction of PP2A binding of [24-3H]OA by addition of OA, MCLR, calyculin-A and tautomycin. The results indicate that the binding of the unlabelled inhibitors to the PP2A molecule causes a dramatic (10(6)-10(8)-fold) increase in the dissociation constant associated with the interaction of [24-3H]OA and PP2A. This suggests that OA and the other inhibitors bind to PP2A in a mutually exclusive manner. The protein phosphatase inhibitors may share the same binding site on the PP2A molecule. We have also measured values of the dissociation constant (Ki) for the interaction of these toxins with protein phosphatase 1 (PP1). For MCLR and calyculin-A, the ratio of the Ki value obtained for PP1 to that for PP2A was in the range 4-9, whereas it was 0.01-0.02 for tautomycin. The value of tautomycin is considerably smaller than that (0.4) calculated from previously reported Ki values.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702557      PMCID: PMC1136572          DOI: 10.1042/bj3060657

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Estimation of the rate constants associated with the inhibitory effect of okadaic acid on type 2A protein phosphatase by time-course analysis.

Authors:  A Takai; Y Ohno; T Yasumoto; G Mieskes
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship.

Authors:  A Takai; M Murata; K Torigoe; M Isobe; G Mieskes; T Yasumoto
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 3.  Protein phosphatases: recent progress.

Authors:  S Shenolikar; A C Nairn
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1991

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Kinetic behavior at high enzyme concentrations. Magnitude of errors of Michelis-Menten and other approximations.

Authors:  S Cha
Journal:  J Biol Chem       Date:  1970-09-25       Impact factor: 5.157

Review 6.  Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.

Authors:  H Fujiki; M Suganuma
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

7.  Cantharidin-binding protein: identification as protein phosphatase 2A.

Authors:  Y M Li; J E Casida
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Inhibitory effect of okadaic acid on the p-nitrophenyl phosphate phosphatase activity of protein phosphatases.

Authors:  A Takai; G Mieskes
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

9.  Affinity of okadaic acid to type-1 and type-2A protein phosphatases is markedly reduced by oxidation of its 27-hydroxyl group.

Authors:  K Sasaki; M Murata; T Yasumoto; G Mieskes; A Takai
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

10.  Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.

Authors:  Y M Li; C Mackintosh; J E Casida
Journal:  Biochem Pharmacol       Date:  1993-10-19       Impact factor: 5.858

View more
  29 in total

1.  Structure-based thermodynamic analysis of the dissociation of protein phosphatase-1 catalytic subunit and microcystin-LR docked complexes.

Authors:  P Lavigne; J R Bagu; R Boyko; L Willard; C F Holmes; B D Sykes
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

2.  A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.

Authors:  Heng-Hong Li; Xin Cai; Geoffrey P Shouse; Landon G Piluso; Xuan Liu
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

3.  Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors.

Authors:  T Misteli; D L Spector
Journal:  Mol Biol Cell       Date:  1996-10       Impact factor: 4.138

4.  Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding.

Authors:  H B Huang; A Horiuchi; J Goldberg; P Greengard; A C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Greatwall-phosphorylated Endosulfine is both an inhibitor and a substrate of PP2A-B55 heterotrimers.

Authors:  Byron C Williams; Joshua J Filter; Kristina A Blake-Hodek; Brian E Wadzinski; Nicholas J Fuda; David Shalloway; Michael L Goldberg
Journal:  Elife       Date:  2014-03-11       Impact factor: 8.140

6.  Effects of modification of the hydrophobic C-1-C-16 segment of tautomycin on its affinity to type-1 and type-2A protein phosphatases.

Authors:  A Takai; K Tsuboi; M Koyasu; M Isobe
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

7.  Functional analysis of the PP2A subfamily of protein phosphatases in regulating Drosophila S6 kinase.

Authors:  Vincent A Bielinski; Marc C Mumby
Journal:  Exp Cell Res       Date:  2007-05-16       Impact factor: 3.905

Review 8.  Calyculins and related marine natural products as serine-threonine protein phosphatase PP1 and PP2A inhibitors and total syntheses of calyculin A, B, and C.

Authors:  Annika E Fagerholm; Damien Habrant; Ari M P Koskinen
Journal:  Mar Drugs       Date:  2010-01-21       Impact factor: 5.118

9.  Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.

Authors:  Adam R Cole; Marc P M Soutar; Makoto Rembutsu; Lidy van Aalten; C James Hastie; Hilary McLauchlan; Mark Peggie; Martin Balastik; Kun Ping Lu; Calum Sutherland
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

10.  Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors:  Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.